Wikidata

(Q40505812)

English

Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15475436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15475436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40505812&oldid=1495970901"